Scope: This article addresses documentation and record review for laboratory research materials. It does not provide clinical, diagnostic, dosing, administration, or human-use guidance.
Different methods answer different questions
High-performance liquid chromatography (HPLC) and mass spectrometry (MS) are often listed together on peptide testing documents, but the two methods do not report the same property. HPLC separates detected components under defined chromatographic conditions. Mass spectrometry measures mass-to-charge signals that can support an identity assessment.
A strong review reads each result in the context of its method, sample, and lot. Neither an instrument name nor a single percentage should be treated as a complete characterization of a material.
What an HPLC result can show
In an HPLC analysis, a prepared sample moves through a chromatographic system and detected components appear as peaks. A report may express a principal peak as a percentage of the total integrated peak area observed under the stated method. That result can help describe chromatographic purity or the relative distribution of detected components.
The number remains method-dependent. Column chemistry, mobile phase, gradient, detector wavelength, integration settings, sample preparation, and the response of individual components can all affect what is separated or detected. An HPLC area percentage does not automatically establish molecular identity, exact net peptide content, sterility, endotoxin status, or every possible impurity.
When reviewing the record, look for the method designation, detector, reported area percentage, chromatogram, retention information, integration table, and any specification or acceptance criterion used by the laboratory.
What a mass-spectrometry result can show
Mass spectrometry produces signals based on the mass-to-charge ratio of detected ions. For a synthetic peptide with an expected composition, measured signals can be compared with expected mass-related values to support an identity assessment. Depending on the method, a report may show a deconvoluted molecular mass, multiple charge states, or fragment information.
A matching mass-related signal is useful evidence, but it does not automatically quantify total material, prove chromatographic purity, or rule out every closely related structure or impurity. The meaning depends on the instrument, acquisition method, mass accuracy, sample preparation, data processing, and comparison criteria.
Look for the expected and observed values, units, mass tolerance, spectrum or data table, instrument or method description, and an explicit interpretation from the issuing laboratory.
Why HPLC and MS are complementary
HPLC can separate and estimate the relative signal contribution of detected components, while MS can provide mass-related evidence relevant to identity. Used together, the methods can support a more informative record than either result alone because they address different analytical questions.
Complementary evidence still has boundaries. A document should state the tests actually performed and avoid turning an HPLC-plus-MS result into claims about attributes that were not evaluated. NIST guidance on chemical-purity assessment emphasizes assembling a convincing body of evidence using fit-for-purpose measurements rather than relying on a single technique.
How to read common COA statements
- “HPLC purity: 99%” — usually a chromatographic result under the report’s stated conditions; check the basis, chromatogram, and integration table.
- “MS conforms” — should be supported by expected and observed mass-related values and a stated comparison criterion.
- “Pass” — has limited meaning unless the report identifies the method, specification, result, and acceptance limit.
- “Identity confirmed” — review which identity test was performed and whether the underlying spectrum or data are included.
- “99%+ tested” — is incomplete marketing language unless it identifies the method, document source, sample, and applicable lot.
If the full data are unavailable, record that limitation. Do not infer missing results from a summary badge or transfer a result from one variant or lot to another.
Minimum fields for a useful testing record
- Product or compound name and exact strength or variant
- Lot, batch, sample, and report identifiers
- Issuing laboratory and document source
- Sample-receipt, test, and report dates when available
- Analytical method and relevant instrument or method designation
- Expected value, observed result, units, and acceptance criterion
- Chromatogram, spectrum, integration table, or supporting data
- Review status, limitations, and any superseded document version
These fields help connect the analytical evidence to the exact material it covers and make later review possible without relying on a detached screenshot or summary percentage.
Primary references for further reading
- NIST Special Publication 1012: traceable assessment of chemical purity
- Characterization of Synthetic Peptides by Mass Spectrometry
- Liquid Chromatography–High Resolution Mass Spectrometry for peptide quality control
These sources provide analytical context. They do not validate any specific Better Life Aminos product, supplier document, laboratory, or lot.
Documentation principle
Connect every claim to its source, every report to the material it covers, and every result to the method and lot identified on the document.